Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Left out in the cold: Moving beyond hormonal therapy for the treatment of immunologically cold prostate cancer with CAR T cell immunotherapies.

Autor: Porter LH; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC 3800, Australia., Harrison SG; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC 3800, Australia., Risbridger GP; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC 3800, Australia; Cancer Immunology Program, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Cabrini Institute, Cabrini Health, Malvern, VIC 3144, Australia., Lister N; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC 3800, Australia., Taylor RA; Cancer Immunology Program, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia; Cabrini Institute, Cabrini Health, Malvern, VIC 3144, Australia; Prostate Cancer Research Group, Monash Biomedicine Discovery Institute, Cancer Program, Department of Physiology, Monash University, Clayton, VIC 3800, Australia. Electronic address: renea.taylor@monash.edu.

Publikováno v: The Journal of steroid biochemistry and molecular biology [J Steroid Biochem Mol Biol] 2024 Oct; Vol. 243, pp. 106571. Date of Electronic Publication: 2024 Jun 22.

Defining the challenges and opportunities for using patient-derived models in prostate cancer research.

Autor: Brennen WN; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center (SKCCC), Johns Hopkins University, Baltimore, Maryland, USA.; Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland, USA.; Department of Pharmacology & Molecular Sciences, Johns Hopkins University, Baltimore, Maryland, USA., Le Magnen C; Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Urology, University Hospital Basel, Basel, Switzerland.; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland., Karkampouna S; Urology Research Laboratory, Department for BioMedical Research, University of Bern, Bern, Switzerland., Anselmino N; Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Bock N; School of Biomedical Sciences at Translational Research Institute, Faculty of Health, Queensland University of Technology (QUT), Brisbane, QLD, Australia.; Max Planck Queensland Centre for the Materials Science of Extracellular Matrices, Queensland University of Technology (QUT), Brisbane, QLD, Australia.; Centre for Biomedical Technologies, Queensland University of Technology, Brisbane, QLD, Australia., Choo N; Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute Cancer Program, Monash University, Clayton, VIC, Australia., Clark AK; Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute Cancer Program, Monash University, Clayton, VIC, Australia., Coleman IM; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Dolgos R; Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland.; Department of Urology, University Hospital Basel, Basel, Switzerland.; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland., Ferguson AM; Department for BioMedical Research, University of Bern, Bern, Switzerland.; Katharina Gaus Light Microscopy Facility, Mark Wainwright Analytical Centre, Division of Research and Enterprise, University of New South Wales, Sydney, NSW, Australia., Goode DL; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia., Krutihof-de Julio M; Urology Research Laboratory, Department for BioMedical Research, University of Bern, Bern, Switzerland.; Department of Urology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department for BioMedical Research, Translational Organoid Resource, University of Bern, Bern, Switzerland., Navone NM; Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Nelson PS; Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, Washington, USA., O'Neill E; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Porter LH; Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute Cancer Program, Monash University, Clayton, VIC, Australia., Ranasinghe W; Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute Cancer Program, Monash University, Clayton, VIC, Australia.; Department of Surgery, Monash University, Melbourne, VIC, Australia.; Department of Urology, Monash Health, Melbourne, VIC, Australia.; Department of Urology, Austin Health, Melbourne, VIC, Australia., Sunada T; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan., Williams ED; School of Biomedical Sciences at Translational Research Institute, Faculty of Health, Queensland University of Technology (QUT), Brisbane, QLD, Australia.; Australian Prostate Cancer Research Centre-Queensland, Brisbane, QLD, Australia.; Centre for Genomics and Personalised Health, Queensland University of Technology (QUT), Brisbane, QLD, Australia., Butler LM; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, SA, Australia.; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia., Corey E; Department of Urology, University of Washington, Seattle, Washington, USA., van Weerden WM; Department of Urology, Erasmus Medical Center, Rotterdam, The Netherlands., Taylor RA; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.; Department of Physiology, Biomedicine Discovery Institute Cancer Program, Monash University, Clayton, VIC, Australia.; Cabrini Institute, Cabrini Health, Malvern, VIC, Australia.; Melbourne Urological Research Alliance, Biomedicine Discovery Institute, Monash University, Melbourne, VIC, Australia., Risbridger GP; Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute Cancer Program, Monash University, Clayton, VIC, Australia.; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.; Cabrini Institute, Cabrini Health, Malvern, VIC, Australia.; Melbourne Urological Research Alliance, Biomedicine Discovery Institute, Monash University, Melbourne, VIC, Australia., Lawrence MG; Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute Cancer Program, Monash University, Clayton, VIC, Australia.; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.; Cabrini Institute, Cabrini Health, Malvern, VIC, Australia.; Melbourne Urological Research Alliance, Biomedicine Discovery Institute, Monash University, Melbourne, VIC, Australia.

Publikováno v: The Prostate [Prostate] 2024 May; Vol. 84 (7), pp. 623-635. Date of Electronic Publication: 2024 Mar 07.

The future of patient-derived xenografts in prostate cancer research.

Autor: Lawrence MG; Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia. mitchell.lawrence@monash.edu.; Melbourne Urological Research Alliance, Monash Biomedicine Discovery Institute, Clayton, Victoria, Australia. mitchell.lawrence@monash.edu.; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. mitchell.lawrence@monash.edu.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia. mitchell.lawrence@monash.edu.; Cabrini Institute, Cabrini Health, Malvern, Victoria, Australia. mitchell.lawrence@monash.edu., Taylor RA; Melbourne Urological Research Alliance, Monash Biomedicine Discovery Institute, Clayton, Victoria, Australia.; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Cabrini Institute, Cabrini Health, Malvern, Victoria, Australia.; Department of Physiology, Monash University, Clayton, Victoria, Australia., Cuffe GB; Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia., Ang LS; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Clark AK; Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia.; Department of Urology, Radboud University Medical Center, Nijmegen, Netherlands., Goode DL; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Porter LH; Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia., Le Magnen C; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.; Department of Urology, University Hospital Basel, Basel, Switzerland.; Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland., Navone NM; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Schalken JA; Department of Urology, Radboud University Medical Center, Nijmegen, Netherlands., Wang Y; Vancouver Prostate Centre, Vancouver, British Columbia, Canada.; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Experimental Therapeutics, BC Cancer Agency, Vancouver, British Columbia, Canada., van Weerden WM; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Corey E; Department of Urology, University of Washington, Seattle, WA, USA., Isaacs JT; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center (SKCCC), Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Pharmacology and Molecular Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Nelson PS; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Urology, University of Washington, Seattle, WA, USA., Risbridger GP; Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia. gail.risbridger@monash.edu.; Melbourne Urological Research Alliance, Monash Biomedicine Discovery Institute, Clayton, Victoria, Australia. gail.risbridger@monash.edu.; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. gail.risbridger@monash.edu.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia. gail.risbridger@monash.edu.; Cabrini Institute, Cabrini Health, Malvern, Victoria, Australia. gail.risbridger@monash.edu.

Publikováno v: Nature reviews. Urology [Nat Rev Urol] 2023 Jun; Vol. 20 (6), pp. 371-384. Date of Electronic Publication: 2023 Jan 17.